Stroke Research Programme

Stroke is a leading cause of death and disability globally. In Australia, there are 60,000 new cases of stroke every year and it is estimated that over 250,000 people are presently living with the effects of stroke. The global burden of stroke is estimated at 33 million people who are chronically disabled following stroke.

People within this group
Current Research Focus

Stem cell therapy for stroke

Adult human DPSC are ideal for treatment after stroke as they have the potential to become neurons. We have previously demonstrated in rats that DPSC injected into the brain 24 hours after a stroke can improve neurological function. We are now evaluating whether intravenous administration of DPSC can also have a positive effect on brain function. We are also investigating whether these same improvements in disability occur when DPSC are administered later, in the chronic phase of stroke.

Neurogenic potential of DPSC from older teeth

A major aim of our group is to consider autologous therapy, in which DPSC from one’s own teeth may be used to treat one after stroke. This is a much safer option as the cells are not likely to be rejected. Given that 80% of stroke patients are over 55 years of age, it is important that the neurogenic potential (ability to become neurons) of DPSC from older teeth is investigated. We have conducted a comparison of the neurogenic potential of DPSC isolated from the teeth of patients from a range of ages, demonstrating that DPSC from older teeth are as capable of generating neurons as DPSC from younger teeth.

The TOOTH stroke study

Following our positive pre-clinical studies, we are developing the first clinical trial of autologous DPSC therapy in chronic stroke patients: The open study of dental pulp stem cell therapy in humans, or TOOTH stroke study. This trial aims to test the safety and efficacy of autologous DPSC treatment and has the potential to improve the quality of life of patients living with stroke disability.

Mechanisms through which DPSC improve functional outcomes after stroke

We have demonstrated that an intra-cerebral injection of DPSC results in an improvement in brain function in a rat model of stroke. However, we have found, as have others, that few stem cells survive long-term in the brain and the idea that improvement is due to neural cell replacement is highly unlikely. There are a number of possible mechanisms of action which may underlie how DPSC improve brain function, which we are investigating:

  • How transplanted DPSC interact with and influence endogenous neural stem cells;
  • How transplanted DPSC interact with and influence the perineuronal net, and thus, promote neuroplasticity;
  • How transplanted DPSC interact with and influence the glial scar, which forms in response to stroke and can limit the repair of damaged tissue.
Get in touch
+61 8 8128 4000 info@sahmri.com
You can't miss us!
North Terrace Adelaide 5000 South Australia
Postal Address
PO BOX 11060 Adelaide 5001 South Australia
Key Partners
SAHMRI is located on the traditional lands of the Kaurna Nation.

The SAHMRI community acknowledges and respects the traditional owners, the family clans who are the Kaurna Nation from the Adelaide Plains region of South Australia. We acknowledge the clans of the Kaurna Nation and the sacred knowledge they hold for their country. We pay our respects to the Kaurna Nation, their ancestors and the descendants of these living family clans today.